<DOC>
	<DOCNO>NCT02178137</DOCNO>
	<brief_summary>There intensive search substance disease-modifying activity osteoarthritis . A number medication report benefit slow progression knee OA . This trial first head head comparison medication . Patients age age 40 65 enrol . Patients assess clinically use two score system , WOMAC index knee arthritis SF 36 overall physical mental health . The knee X ray assessed Kellgren Lawrence grade also measure joint space narrow follow . The response arthritis medication slow cartilage loss measure biochemically COMP level .</brief_summary>
	<brief_title>Effect Interventions Progression Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Zinc Sulfate</mesh_term>
	<criteria>Patients either sex age 40 65 year mild moderate osteoarthritis knee . Patients history knee pain least 6 month majority day precede month Each joint score separately one patient bilateral knee osteoarthritis count 2 knee . The osteoarthritis grade basis clinical score well see appropriately position x ray use Kellgren Lawrence grading . ( Tibio femoral osteophyte least 1 mm , Kellgren Lawrence grade 2 3 ) Patients diabetes sent diabetes clinic include HbA1c level become normal . Patients give Informed consent Patients severe end stage tricompartmental osteoarthritis knee . Presence uncontrolled systemic disease like chronic liver renal disease Patients diagnosis osteoarthritis , knee arthritis due rheumatoid disease , gout , post traumatic arthritis Patients history surgery knee knee exclude Pregnant lactate mother Patients chronic anaemia Patients get injection affect knee</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>